YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly to buy Verve Therapeutics for $1.3B

Posted online

Eli Lilly has agreed to buy gene-editing startup Verve Therapeutics.

The deal is valued at up to $1.3 billion.

The agreement calls for an upfront payment of $1 billion, and $300 million will be paid out based on the completion of certain clinical milestones.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From The Ground Up: Cheyenne Road multi-use trail with bridge

Complete with a 45-foot pedestrian bridge, this project adds a 10-foot-wide walking trail in front of Nixa’s High Pointe Elementary School and Summit Intermediate School.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences